Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ine Lowyck

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Gastro-Enterologica Belgica|March 12, 2008
Statins in hepatobiliary diseases: effects, indications and risksIne Lowyck, Johan Fevery
Diabetes Care|October 17, 2020
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE StudySara Charleer, Christophe De Block, Frank Nobels, et al.
Diabetologia|February 11, 2025
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort studyJolien De Meulemeester, Bart Keymeulen, Christophe De Block, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Gastro-Enterologica Belgica|March 12, 2008
Statins in hepatobiliary diseases: effects, indications and risksIne Lowyck, Johan Fevery
Diabetes Care|October 17, 2020
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE StudySara Charleer, Christophe De Block, Frank Nobels, et al.
Diabetologia|February 11, 2025
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort studyJolien De Meulemeester, Bart Keymeulen, Christophe De Block, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Pageof 1